 BRIDGEWATER, N.J., Nov. 13, 2020 PRNewswire -- Insmed Incorporated Nasdaq: INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the European Medicines Agency EMA has granted Priority Medicines... 